Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us prof. dr. E.G.E. (Elisabeth) de Vries
University Medical Center Groningen

prof. dr. E.G.E. (Elisabeth) de Vries

Professor
No picture available
E-mail:
e.g.e.de.vries umcg.nl

Publications

18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial

Author Correction: Whole-body CD8 + T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer

COVID-19 Vaccine Effectiveness in Patients with Hematologic Malignancies: a Nationwide Cohort Study

Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Elevated target expression by dual PD-L1 and 4-1BB engagement is associated with 89Zr-PD-L1x4-1BB bispecific Mabcalin tumor uptake.

From Algorithms to Meaningful Biomarkers: Anchoring AI in Clinical Oncology

Interassay Comparison With Digital Image Analysis of Four Routine HER2 Immunohistochemistry Assays in Primary Breast Cancer and Its Metastasis

Automated Whole-Body PET/CT Lesion Tracking for Lesion-Wise Response Evaluation in Metastatic Breast Cancer

Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer

Press/media

FORESIGHT: efficiëntere geneesmiddelontwikkeling dankzij imaging

Voor toekomstbestendige geneesmiddelenzorg is de wetenschap onmisbaar

FORESIGHT doet onderzoek naar juiste patiënt en passende therapie

Major funding boost for molecular imaging in drug development

FORESIGHT Consortium Harnesses Molecular Imaging and AI to Transform Immunotherapy Development

New consortium for immunotherapy research

FORESIGHT consortium encourages molecular imaging in developing new drugs

FORESIGHT consortium secures €9 million to fast-track drug development

Inschrijving 30e Oncologiedagen geopend

Van Laarhoven nieuw lid raad van toezicht IKNL